News Daily News Worse TAVI and M-TEER Outcomes Seen With Low-Volume Operators Michael O'Riordan January 22, 2026
News Daily News FDA Approves Sapien M3 for Transseptal Mitral Valve Replacement Michael O'Riordan December 23, 2025
News Conference News ESC 2025 ESC/EACTS Release New Valvular Heart Disease Guidelines Yael L. Maxwell September 03, 2025
News Daily News People With Tricuspid Valve Disease Want More Information, Sooner Yael L. Maxwell July 17, 2025
News Daily News Tendyne Approved in US for High-risk Patients With Mitral Valve Disease Michael O'Riordan May 28, 2025
News Opinion Editor's Corner ACC 2025 What’s Going to Be Hot at ACC 2025? Michael O'Riordan March 26, 2025
News Daily News Some Mitral TEER Patients Slipping Through the Cracks in the First Month Michael O'Riordan March 21, 2025
News Daily News CMS Agrees to Reimburse Transcatheter Tricuspid Valve Replacement Todd Neale March 20, 2025
News Features Reimbursement Issues Seem to Be Holding Renal Denervation Back Todd Neale December 19, 2024
News Conference News PCR London Valves 2024 Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes Michael O'Riordan November 26, 2024
News Conference News PCR London Valves 2024 Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice Michael O'Riordan November 25, 2024
News Conference News TCT 2024 Pooled All-Female Analysis Support Benefits of TAVI Over SAVR L.A. McKeown November 01, 2024
News Conference News TCT 2024 TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation Michael O'Riordan October 30, 2024
News Conference News TCT 2024 TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR Michael O'Riordan October 29, 2024